91,112 results on '"Gastric cancer"'
Search Results
152. Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy (Dragon)
153. The Bacterial Composition of the Stomach in Reflux Disease
154. Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore
155. A Study of CDX-585 in Patients With Advanced Malignancies
156. Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC
157. ONS in Gastric Cancer After Total Gastrectomy
158. Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.
159. Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
160. FOG-001 in Locally Advanced or Metastatic Solid Tumors
161. Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
162. A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
163. A Study of TAS-120 in Patients With Advanced Solid Tumors
164. Opportunistic Gastric Cancer Screening (ROCGAS)
165. Combined Exercise and Nutritional Intervention in GI Cancer Patients
166. Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients (CapnoGI)
167. Personalized DC Vaccine for Postoperative Cancer
168. Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
169. Metronomic Capecitabine in Stage III Gastric Cancer
170. Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
171. Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
172. Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer
173. Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America (GASPAR)
174. Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive
175. KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
176. Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology
177. Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer
178. Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer
179. Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. (SkinHealth)
180. Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma
181. Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
182. A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)
183. Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG (IMAGINE)
184. Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer
185. XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)
186. Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
187. Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong
188. Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
189. A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
190. A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
191. A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
192. 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer (PHANTOM)
193. A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer
194. Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
195. Resilience and Equity in Aging, Cancer, and Health (REACH) (REACH)
196. Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors
197. A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
198. The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. (EPICURE)
199. Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
200. Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence (CHIMERA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.